Associated Retinal Consultants, P.C.
Associated Retinal Consultants, P.C.
Royal Oak, Michigan, United States5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD | Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 2 | 2026-09-10 | NCT06659445 | |
| Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Visual Impairment, eye disorder, nervous system disorder, vision disorder | Recruiting | Phase 3 | 2026-08-20 | NCT05844982 | |
| Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD | Neovascular Age-related Macular Degeneration | Active, not recruiting | Phase 3 | 2026-07-07 | NCT05904028 | |
| Retinal Detachment Prevention (Laser Prophylaxis) in Stickler Syndrome (SS) | Stickler syndrome type 1, Stickler syndrome type 2, eye disorder, retinal detachment, retinal disorder, retinal perforation | Recruiting | Not applicable | 2026-07-01 | NCT07146516 | |
| Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration | Neovascular Age-related Macular Degeneration | Active, not recruiting | Phase 3 | 2025-06-17 | NCT06495918 |